Side effects, images, and drug details for Braftovi - Inside Rx
Back to Search Results

Braftovi

encorafenib
Encorafenib is used in combination with a medicine called binimetinib (Mektovi) to treat melanoma (skin cancer) that cannot be treated with surgery or has spread to other parts of the body. Encorafenib is used in combination with a medicine called cetuximab (Erbitux) to treat colorectal cancer that has spread to other parts of the body. Encorafenib is used only if your cancer has a specific genetic marker (an abnormal "BRAF" gene). Your doctor will test you for this gene. Encorafenib may also be used for purposes not listed in this medication guide.
CHEMICAL NAME
encorafenib
DRUG TYPE
multikinase inhibitors

Frequently Asked Questions

Encorafenib can harm an unborn baby. Do not use if you are pregnant. Use a non-hormonal form of birth control to prevent pregnancy while using encorafenib and for at least 2 weeks after your last dose.

Although this medicine is used to treat melanoma, using encorafenib may increase your risk of developing other types of skin cancer. Ask your doctor about your specific risk. Tell your doctor if you notice any new skin symptoms.

Similar Drugs

Brand Name Examples Supplied As Strength
Braftovi capsule 75 mg

Save up to 80% on brand & generic medications.